Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Andrea I. Loaiza Perez"'
Autor:
Maria Cristina Soraires Santacruz, Aldana Sólimo, Andrea I. Loaiza Perez, Mariana A. Callero, Elisa Bal de Kier Joffé, Liliana M. Finkielsztein
Publikováno v:
Journal of Cellular Physiology. 233:4677-4687
Breast cancer is the first cause of cancer death in women. Many patients are resistant to current therapies, and even those were sensitive at first may eventually become resistant later. Thiosemicarbazones (TSCs) are synthetic compounds that exhibit
Autor:
Cristina E. Rodríguez, Elisa Bal de Kier Joffé, Aldana Sólimo, Mariana A. Callero, Andrea I. Loaiza Perez
Publikováno v:
Journal of Cellular Biochemistry. 118:2841-2849
Aminoflavone (AFP 464, NSC 710464), an antitumor agent which recently entered phase II clinical trials, acts against estrogen-positive breast cancer (ER+). AFP 464, which has a unique mechanism of action by activating aryl hydrocarbon receptor (AhR)
Autor:
Aldana, Sólimo, Maria Cristina, Soraires Santacruz, Andrea I, Loaiza Perez, Elisa, Bal de Kier Joffé, Liliana M, Finkielsztein, Mariana A, Callero
Publikováno v:
Journal of cellular physiology. 233(6)
Breast cancer is the first cause of cancer death in women. Many patients are resistant to current therapies, and even those were sensitive at first may eventually become resistant later. Thiosemicarbazones (TSCs) are synthetic compounds that exhibit
Autor:
Mariana A, Callero, Cristina E, Rodriguez, Aldana, Sólimo, Elisa, Bal de Kier Joffé, Andrea I, Loaiza Perez
Publikováno v:
Journal of cellular biochemistry. 118(9)
Aminoflavone (AFP 464, NSC 710464), an antitumor agent which recently entered phase II clinical trials, acts against estrogen-positive breast cancer (ER+). AFP 464, which has a unique mechanism of action by activating aryl hydrocarbon receptor (AhR)
Autor:
Mariana A, Callero, Gabriela A, Luzzani, Diana O, De Dios, Tracey D, Bradshaw, Andrea I Loaiza, Perez
Publikováno v:
Journal of cellular biochemistry. 114(10)
2-(4-Amino-3-methylphenyl)-5-fluorobenzothiazole (5F203, NSC 703786) lysylamide belongs to a novel mechanistic class of antitumor agents. It elicits activity against ovarian, breast, kidney and colorectal cancer models. In sensitive breast cancer cel
Autor:
Sólimo, Aldana, Soraires Santacruz, Maria Cristina, Loaiza Perez, Andrea I., Bal de Kier Joffé, Elisa, Finkielsztein, Liliana M., Callero, Mariana A.
Publikováno v:
Journal of Cellular Physiology; Jun2018, Vol. 233 Issue 6, p4677-4687, 11p
Autor:
Luzzani, Gabriela A., Callero, Mariana A., Kuruppu, Anchala I., Trapani, Valentina, Flumian, Carolina, Todaro, Laura, Bradshaw, Tracey D., Loaiza Perez, Andrea I.
Publikováno v:
Journal of Cellular Biochemistry; Dec2017, Vol. 118 Issue 12, p4526-4535, 10p
Publikováno v:
Journal of Cellular Biochemistry; Dec2017, Vol. 118 Issue 12, p4109-4120, 12p
Autor:
Callero, Mariana A., Rodriguez, Cristina E., Sólimo, Aldana, Bal de Kier Joffé, Elisa, Loaiza Perez, Andrea I.
Publikováno v:
Journal of Cellular Biochemistry; Sep2017, Vol. 118 Issue 9, p2841-2849, 9p
Publikováno v:
Journal of Cellular Biochemistry; Sep2017, Vol. 118 Issue 9, p2475-2483, 9p